Company | 合法醫療器材資訊網

iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful ... Read More

iCAD is a global leader in advanced breast cancer detection solutions built on artificial intelligence that empower radiologists to find cancers earlier while ... Read More

iCAD is a global leader in medical technology providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful ... Read More

(NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that ProFound AI® Version ... Read More

由 CR Gomez 著作 · 2009 · 被引用 12 次 — The medical treatment of patients with symptomatic intracranial atherosclerotic disease (ICAD) is directed toward reducing the risk of new ischemic events. Read More

Intracranial atherosclerotic disease (ICAD) is an important cause of ischemic stroke and accounts for more than 5–10% of all ischemic stroke cases. ... ICAD is as ... Read More

Intracranial atherosclerotic disease (ICAD) can affect cerebral arteries distal to the internal carotid arteries (ICAs) after they enter the petrosal bone (C2 segment​) ... Read More

Trends in healthcare — iCAD Inc. (NASDAQ: ICAD), headquartered in Nashua, New Hampshire, is a medical-device manufacturer. iCAD makes cancer ... Read More

iCAD | 4154 followers on LinkedIn. | iCAD is a leading global provider of advanced image analysis, workflow solutions and radiation therapies for the early ... Read More

由 R Sangha 著作 · 2016 — Background:The SAMMPRIS trial included aggressive medical management (​AMM) composed of dual antiplatelets (aspirin, clopidogrel), high ... Read More